CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Forest Laboratories, LLC v. Lupin Limited

1:14-cv-01058

Overview

Case Number 1:14-cv-01058
Filing Date 2014-08-15
Status Terminated
Termination Date 2018-03-30
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Forest Laboratories, LLC Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Amerigen Pharmaceuticals Inc. Operating Company

Represented By

1 Attorneys Listed

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Anchen Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Stephanie E. O'Byrne

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6067

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Par Pharmaceutical Inc. Operating Company

Represented By

2 Attorneys Listed

Stephanie E. O'Byrne

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6067

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Lupin Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Bayard, P.A., 600 N. King Street

Richard D. Kirk

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

ADDRESS EXPIRED / UNKNOWN, (302) 655-5000

Plaintiff

Forest Laboratories Holdings Ltd. NPE (Patent Assertion Entity)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Amerigen Pharmaceuticals Ltd. Operating Company

Represented By

1 Attorneys Listed

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Lupin Pharmaceuticals Inc. Operating Company

Represented By

3 Attorneys Listed

Clifford E. Katz

Email: ckatz@kelleydrye.com

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Bayard, P.A., 600 N. King Street

Richard D. Kirk

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

ADDRESS EXPIRED / UNKNOWN, (302) 655-5000

Counter Defendant

Adamas Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8039009
Modified release formulations of memantine oral dosage forms
Filed: 2005-06-16
Issued: 2011-10-18
Active (2.3 yrs remaining) +1377d PTA
Expires: 2029-03-24

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1377 days) / Cellect Scrutiny — Over 1377 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

38

Dispositive

0

Granted

0

Denied

1

Pending / Review

36

Motions by Category

Procedural / Extension Motion 5 Claim Construction / Markman Filing 33

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
MEMORANDUM OPINION re claim construction. Signed by Judge Leonard P. Stark on 1/5/16. Associated Cases: 1:14-cv-00121-LPS et al. (ntl) (Entered: 01/05/2016)
Entry #170 • 2016-01-05 Document →
Claim Construction / Markman Filing Denied
ORDER re (201 in 1:14-cv-00200-LPS, 130 in 1:14-cv-01271-LPS, 170 in 1:14-cv-01058-LPS, 180 in 1:14-cv-00686-LPS, 224 in 1:14-cv-00508-LPS, 194 in 1:14-cv-00121...
Entry #171 • 2016-01-05 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a revised schedule to October 8, 2015 - filed by Adamas Pharmaceuticals Inc., Forest Laboratories Holdings ...
Entry #161 • 2015-10-07 Document →
Claim Construction / Markman Filing Pending / Under Review
Official Transcript of Claim Construction Hearing held on August 3, 2015 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573...
Entry #149 • 2015-08-31 Document →
Claim Construction / Markman Filing Pending
Markman Hearing
Entry #— • 2015-08-03
Claim Construction / Markman Filing Pending / Under Review
REPLY BRIEF re 123 MOTION to Strike the Reply Declaration of Richard F. Bergstrom and the Related Portions of Defendants' Reply Claim Construction Brief filed b...
Entry #128 • 2015-08-02 Document →

Docket Entries

(195 total)
Pleading / Complaint

COMPLAINT filed against Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Anchen Pharmaceuticals Inc., Lupin Limited, Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1572099.) - filed by Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd., Forest Laboratories, LLC. (Attachments: # 1 Exhibit A-G, # 2 Civil Cover Sheet)(els) (Entered: 08/18/2014)

Entry #1 • 2014-08-15
1
Pleading / Complaint

COMPLAINT filed against Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Anchen Pharmaceuticals Inc., Lupin Limited, Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1572099.) - filed by Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd., Forest Laboratories, LLC. (Attachments: # 1 Exhibit A-G, # 2 Civil Cover Sheet)(els) (Entered: 08/18/2014)

Entry #1 • 2014-08-15
2
Pleading / Complaint

COMPLAINT filed against Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Anchen Pharmaceuticals Inc., Lupin Limited, Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1572099.) - filed by Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd., Forest Laboratories, LLC. (Attachments: # 1 Exhibit A-G, # 2 Civil Cover Sheet)(els) (Entered: 08/18/2014)

Entry #1 • 2014-08-15
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 08/18/2014)

Entry #2 • 2014-08-15
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/6/14. Date of Expiration of Patent: 3/24/29, 11/22/25.Thirty Month Stay Deadline: 2/6/2017. Amerigen Pharmaceuticals Inc.(els) (Entered: 08/18/2014)

Entry #3 • 2014-08-15
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc